The Medical Devices (Draft Amendment) Rules, 2022.

The dossier should contain a list of all materials of animal or human origin used in the device. For these materials, detailed information should be provided concerning the selection of sources or donors; the harvesting, processing, preservation, testing and handling of tissues, cells and substances of such origin should also be provided. Process validation results should be included to substantiate that manufacturing procedures are in place to minimize biological risks, in particular, with regard to viruses and other transmissible agents. Transmissible Spongiform Encephalopathies (TSE) or Bovine Spongiform Encephalopathy (BSE) Certificates should also be submitted.

DPIIT registered Start-ups and registered MSMEs for Testing & Certification of Telecom Products get total exemption of testing & certification fees for their products.

In order to support and encourage ecosystem for Start-ups and MSMEs in Telecom and related ICT sector, Telecommunication Engineering Centre (TEC), the technical body under Department of Telecommunications (DOT) has incentivized DPIIT registered Start-ups and registered MSMEs for Testing & Certification of Telecom Products under Voluntary Certification Scheme of TEC by total exemption of testing & certification fees for their products.

Faceless Inquiry or Valuation Scheme, 2022

As per the scheme, making inquiry before assessment, directing the assessee to get his accounts audited and estimating the value of any asset, property or investment by a Valuation Officer as per Income Tax Act, shall be in a faceless manner, through automated allocation.

SEBI notifies timeline for rebalancing portfolio of mutual fund schemes.

The mandatory rebalancing period for all mutual fund schemes except index funds and exchange-traded funds (ETFs) is 30 business days and if the portfolio of schemes is not rebalanced within the mandated time frame, justification in writing, including the details of the efforts made to rebalance the portfolio, should be placed before an investment committee.